News

MaSTherCell expands production by doubling its capacity

GOSSELIES, BELGIUM – November 30, 2018 – MaSTherCell S.A. a subsidiary of Orgenesis Inc. (NASDAQ: ORGS) through Masthercell Global Inc., a cell therapy-dedicated Contract Development and Manufacturing Organization (CDMO) launched a new production wing of 600 m² at its Belgium site in the presence of the Minister-President of Wallonia, Willy Borsus. Masthercell is also backed by Great Point Partners, LLC (“GPP”), a leading healthcare investment firm based in Greenwich, Connecticut. Discover the official press release here

Read more

A first in Belgium: A mutuality involved in funding molecular diagnostic tests for cancer

Gosselies and La Louvière, Belgium. The Mutualité Libérale Namur-Hainaut announces funding for the OncoDNA Company’s genetic profiling test. This initiative is a first in Belgium and a major step towards precision médicine. Each adult member who has a stage 3 or 4 solid tumour cancer and relapses after first-line treatment will receive a partial reimbursement for their tumour analysis known as “OncoDEEP”, amounting to €1,500, or around half of its cost. Discover the official press release here.

Read more